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Lactic Acid Bacteria (LAB) are ancient organisms that cannot biosynthesize functional
cytochromes, and cannot get ATP from respiration. Besides sugar fermentation,
they evolved electrogenic decarboxylations and ATP-forming deiminations. The right
balance between sugar fermentation and decarboxylation/deimination ensures buffered
environments thus enabling LAB to survive in human gastric trait and colonize gut. A
complex molecular cross-talk between LAB and host exists. LAB moonlight proteins are
made in response to gut stimuli and promote bacterial adhesion to mucosa and stimulate
immune cells. Similarly, when LAB are present, human enterocytes activate specific
gene expression of specific genes only. Furthermore, LAB antagonistic relationships with
other microorganisms constitute the basis for their anti-infective role. Histamine and
tyramine are LAB bioactive catabolites that act on the CNS, causing hypertension and
allergies. Nevertheless, some LAB biosynthesize both gamma-amino-butyrate (GABA),
that has relaxing effect on gut smooth muscles, and beta-phenylethylamine, that controls
satiety and mood. Since LAB have reduced amino acid biosynthetic abilities, they
developed a sophisticated proteolytic system, that is also involved in antihypertensive
and opiod peptide generation from milk proteins. Short-chain fatty acids are glycolytic and
phosphoketolase end-products, regulating epithelial cell proliferation and differentiation.
Nevertheless, they constitute a supplementary energy source for the host, causing
weight gain. Human metabolism can also be affected by anabolic LAB products such
as conjugated linoleic acids (CLA). Some CLA isomers reduce cancer cell viability and
ameliorate insulin resistance, while others lower the HDL/LDL ratio and modify eicosanoid
production, with detrimental health effects. A further appreciated LAB feature is the
ability to fix selenium into seleno-cysteine. Thus, opening interesting perspectives for their
utilization as antioxidant nutraceutical vectors.
Keywords: selenium, bioactive molecules, proteolysis, exopolysaccharides, CLA, short chain fatty acids,
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SHORT HISTORY OF LACTIC ACID BACTERIA
Lactic acid bacteria (LAB) include a large number of bacterial
genera among which the best known are lactobacilli, lactococci,
enterococci, streptococci, leuconostoc, and pediococci. These
genera differ for morphology, pH and salt tolerance, temperature
optimum, habitats, and pathogenic potential. At present, it is very
difficult to establish a clear demarcation line between beneficial
and virulent species, being some problematic traits more linked
to strain than to species. However, Lactobacilli and Lactococci are
considered GRAS (generally regarded as safe).
LAB were among the first living organisms on the earth: they
appeared about three billions years ago, in the transition period
from anaerobiosis to aerobiosis. Apparently, they seem to be
well adapted to both anaerobic and aerobic life conditions, since
they bear all the necessary proteins for respiration and several
enzymes involved in fermentative pathways. Nevertheless, dur-
ing evolution they never acquired the ability to biosynthesize
heme, an essential component of cytochromes, so they can shift to
respiratory metabolism only with exogenous hemine supplemen-
tation. In the case of pathogenic streptococci, they can subtract
heme from host hemoglobin by means of hemolysin, a protein
considered a virulence factor. Therefore, most LAB species are
compelled to live on fermentation metabolism with lower energy
yields (Carr et al., 2002).
Furthermore, LAB inability to synthesize heme molecules
implies that they cannot get functional heme enzymes such
as peroxidases and catalases that are the most efficient pro-
teins involved in hydroxyl radical scavanging. This results in
an impaired resistance to O2 toxicity. In spite of this, LAB
can tolerate oxygen and are defined microaerophylic organisms
(Brioukhanov and Netrusov, 2007).
Some strategies have been set up by these bacteria to replace
heme enzyme anti reactive oxygen species (ROS) efficacy, for
instance the use of metals as radical scavengers: zinc constitutes
an ion trap for oxygen radicals, (Salvatore et al., 2007) man-
ganese can act as a superoxide dismutase-like system (De Angelis
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and Gobbetti, 1999), while selenium acts in the selenocysteine-
harboring proteins (Calomme et al., 1995). It is known that
LAB species are able to accumulate high intracellular amounts of
manganese (up to 25mM), selenium, and zinc.
During evolution, due to the low energy gain by fermentation
and to the harsh life condition in an “oxidant” world (like the
one in which we now live), LAB have been compelled to special-
ize their metabolism rather toward stress defence than to acquire
strategic biosynthetic abilities. Therefore, they developed sym-
biont/parasite relationships with plants and animals which can
supply vitamins, proteins, and amino acids. It is worth noting
that LAB had acquired the ability to recognize several sugars, such
as for instance xylose, cellobiose, ribose, arabinose, glucose, and
fructose, before they developed the ability to ferment lactose to
lactate, which was made possible only after mammal’s expansion
on the Earth. Therefore, they firstly colonized fruits and veg-
etable ecological niches, and later cheese, wine, and especially
milk, which constitute their election habitat being rich in lactose
(Carr et al., 2002).
It is possible that, in early life, sugar catabolism was not as
predominant as in current LAB metabolism and that parallel
pathways, like acid and amino acid decarboxylations and argi-
nine deimination (ADI), could simultaneously be activated to get
energy on poor media such as cell lysis products (ribose, fatty
acids, amino acids) (Konings, 2006).
However, commensal LAB living in both gut and other
mucosal ecological niches, although fed with abundant nutrients,
still have a stressful life and often are compelled to cope with
antagonistic host factors as well as with yeast or bacteria sharing
the same habitat. These harsh conditions allowed the evolution of
interesting metabolic and cross-talk features.
LAB BIOCHEMISTRY
Most LAB biochemical pathways have been fully elucidated so
far, due to the strategic importance of these bacteria in the food
industry both as starters and as biocontrol agents for food deteri-
oration. Recent interest on LAB as ascertained probiotic agents
has completed the information about LAB metabolism and its
role in the context of the gut ecosystem.
LAB ENERGYMETABOLISM
LAB energy metabolism is chiefly based upon lactic fermenta-
tion, ADI, acid, and amino acid decarboxylation. While sugar
fermentation has a true energetic role, the other pathways can
solve different and more complex functions. Lactic fermentation
is an appreciated feature in both gut and industrial LAB since its
end-product, lactate, by causing acidification, ensures a control
over less friendly bacteria.
Sugar fermentations
Homolactic fermentation. Homolactic fermentation always
results from glycolysis. Obligate homofermentative LAB (pedio-
cocci, lactococci, streptococci, and some lactobacilli) produce
100% lactic acid through the Embden-Mayeroff route from
different hexoses, which are internalized by means of spe-
cific membrane transporters such as permeases and sym-
porters, and then isomerized to glucose or fructose. Galactose
constitutes an exception since it can be either isomerized to
glucose by the Leloir reaction mediated by high energy com-
pounds (UDPGlu-UDPGal) or drifted to glycolysis through the
D-tagatose 6-phosphate route, generating diidroxiacetonphos-
phate, hence glyceraldehyde phosphate (Figure 1).
When a disaccharide, such as lactose or saccharose, is present
it can be hydrolyzed into the two monosaccharides in the exter-
nal environment or rather be uptaken as disaccharide and then
hydrolyzed inside the cell. From each exose, two moles of lactic
acid are produced at the end of the glycolytic process as the result
of pyruvate reduction to lactate, through NADH re-oxidation to
NAD+. Lactic acid can be either in the D or in the L optical
form, depending on each species’ genetic determinants encoding
either D-lactate (D-LDH) or L-lactate (L-LDH) dehydrogenase,
respectively. Some species can produce both D and L lactate as
the result of racemase activity, or due to the presence of genetic
determinants for both LDH isoforms. In this case the second
genetic determinant can derive by horizontal gene transfer. The
most common catabolic pathway, i.e., the conversion of the dis-
accharide lactose into lactate, generates therefore four moles of
lactic acid and four moles of ATP. No gas is produced in the
process. This low energy gain can sometimes be improved by
proton-substrate symport, i.e., lactic acid excretion, generating a
proton gradient: since this system is electrogenic it can increase
the energy yield of LAB.
Facultative homofermenters can direct part of the pyruvic
acid that is generated by glycolysis toward the production of for-
mate, acetate, and ethanol. Pyruvate-formate-lyase can convert
pyruvate (C3) into formate (C1) and acetylCoA (C2). The lat-
ter can undergo transferase reaction into acetyl phosphate and
then conversion into acetate leading to ATP synthesis. Acetate
can be either accumulated in the growth medium or alternatively
reduced to ethanol via acetaldehyde with NADH consumption,
depending on the pH, and reduced pyridine coenzymes availabil-
ity. This route allows one additional ATP mole gain, but less lactic
acid is produced. Since formate can be decarboxylated/oxidized,
an additional CO2 mole can be produced by this pathway (gas
producing bacteria).
Heterolactic fermentation. Heterolactic fermentation concerns
LAB which lack the glycolytic enzyme fructose 1,6 bisphos-
phate aldolase (Leuconostoc, Oenococcus, and some Lactobacillus
species) so they cannot metabolize hexoses through the Embden-
Mayeroff pathway. Therefore, they utilize the pentose-phosphate
route with the transketolase reaction joining the glycolysis
with the three carbon metabolite glyceraldehyde 3-phosphate.
The remaining C2 unit, acetyl phosphate, is then converted
into ethanol or into acetate (the latter reaction resulting in
an additional ATP mole gain), depending on NAD+/NADH
ratio, as previously described for the facultative homofermenters.
Nevertheless, acetate production is not so frequent due to the
necessity of NADH re-oxidation. The energetic yield of the trans-
ketolase pathway is lower than the homolactic fermentation giv-
ing rise only to 1 ATP mole, 0.5 moles of lactate, and 0.5 moles of
ethanol or acetate, per mole of consumed hexose, plus one CO2
mole deriving from the hexose/pentose conversion (by decar-
boxylation). So, the heterofermentative route is gas producing.
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FIGURE 1 | Galactose metabolism in Lactic Acid Bacteria.
All heterofermentative LAB can also degrade pentoses, while
not all homofermenters are also pentose degraders.
Arginine deimination
Besides sugar level phosphorylation, LAB can get energy from
ADI to citrulline and citrulline cleavage to ornithine plus car-
bamoyl phosphate. The latter is then converted into ATP and
carbon dioxide, or rather used for pyrimidine biosynthesis. This
route also generates two moles of ammonia (one from the
arginine-citrulline transition, the second from carbamoyl phos-
phate hydrolysis) useful to compensate the acidity generated by
sugar catabolism to lactic acid, acetic acid, and formic acid, in
both homo- and hetero-fermenting conditions (De Angelis et al.,
2002).
On the other hand, ornithine is exchanged with extracellular
arginine in an ornithine/arginine antiport system ensuring the
continuity of the reactions. In wine, LAB possessing this pathway
have been selected, since the wine environment is still rich in argi-
nine after yeast alcoholic fermentation. Although the ADI route is
somehow similar to an inverted urea cycle, from an evolutionary
view point these pathways are not related at all (Liu et al., 1996).
Acid and amino acid decarboxylations
Apart from its secondary involvement in pH buffering, the argi-
nine deiminase route is chiefly an ATP generating pathway useful
to complement substrate level phosphorylation. On the contrary,
acid and amino acid decarboxylations solve more complex roles
and their evolutionary history is worth to know. Decarboxylations
are coupled with electrogenic antiport systems generating a pro-
ton gradient across the cytoplasm membrane and the overall
system supports a double role: acidity control and proton motive
force (PMF) generation, i.e., supplementary energy in organisms
unable of respiration. In the case of acid decarboxylations, the
reaction concerns dicarboxylic and tricarboxylic acids, like malate
and citrate, and the reaction products are not informational
molecules.
It has been hypothesized that, early in evolution, acid decar-
boxylase activities were mainly directed toward acidification
control. Later, free energy conservation mechanisms have been
acquired by coupling decarboxylation with electrogenic antiport
systems, which allowed more sophisticated cellular responses,
like generation of metabolic energy and a better overall acid
stress resistance. These pathways are believed to having evolved
through horizontal gene transfer allowing antiporter proteins
genes to be located in the same operon as decarboxylase genes,
thus undergoing the same transcriptional control (Makarova and
Koonin, 2007) On the other hand, LAB genomes are known
to encode a highly variable number of genes that suggests that
during evolution gene acquisition/loss has played a crucial role
in determining the present situation. LAB genome size ranges
from the 1.8Mb of L. gasseri to 3.3Mb of L. plantarum and
also the G+C content vary significantly (from 34 to 46%)
(Siezen et al., 2004), suggesting frequent recombination events.
Furthermore, the presence of soluble acid decarboxylases and
membrane bound precursor/product exchangers in LAB (Lucas
et al., 2005), constitutes an intermediate event between the simple
decarboxylation occurring in the cytoplasm of strictly anaer-
obes (like Clostridia and Fusobacterium), where no free energy
is conserved, and the membrane bound complexes (including
decarboxylases and transporters) found in gamma proteobacteria
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in which active sodium extrusion occurs (Makarova et al.,
2006).
For what concerns amino acid decarboxylases, their phys-
iological roles are similar to those of acid decarboxylases,
(Molenaar et al., 1993). Nonetheless, some additional func-
tions like bacteria–bacteria interactions and host-symbiont com-
munication were found, being some products informational
molecules. Glutamate can be decarboxylated to gamma-amino-
butyrate (GABA), histidine to histamine, phenylalanine to
β-phenylethylamine, tyrosine to tyramine, triptophane to trip-
tamine, ornithine to putrescine, lysine to cadaverine (Konings,
2006).
Amino acid decarboxylations are catalyzed by PLP or pyru-
voil dependent enzymes that can be either soluble (Pessione et al.,
2005) or membrane-located. In Enterococcus a membrane bound
tyrosine and phenylalanine decarboxylase has been described
(Pessione et al., 2009): this cellular location can allow a better
interaction between decarboxylase enzyme and transporter pro-
tein. This may constitute a further evolutive step toward a more
efficient system to get energy and to counteract acidic stress in a
less acid-tolerant genus than other LAB (Figure 2).
Some produced amines are bio-active molecules (histamine,
tyramine, triptamine, beta-phenylethyl amine, GABA), acting
at vascular or central nervous system level of human host
(Moreno-Arribas et al., 2003), while others are informational
messengers for microbial cross-talk and for stress control (at
least for putrescine in some bacterial species). All of them
can undergo further bio-transformations by monoamino- and
diamino-oxidases. These routes can thus be considered as
“escape-pathways” during sugar depletion or excessive acidifica-
tion (i.e., stationary phase stress) but also as means to interact
with the external environment. It has to be considered that
most LAB genomes harbor genes for both the ADI pathway
enzymes and amino acid decarboxylases: often these two routes
are reciprocally regulated (Lactobacillus, Lactococcus) (Lamberti
et al., 2011a,b) but sometimes they do not compete and are
parallely used (Enterococcus), underlining their similar but dif-
ferent physiological function. Proteomic studies can add useful
information about the physiological and environmental modu-
lations acting on these foundmental pathways. From a human
point of view, while acid decarboxylations are appreciated because
they reduce acidity (i.e., in wine), amino acid decarboxylations,
FIGURE 2 | Zoom of the proteomic maps of the membrane-enriched
protein fraction of a tyramine and beta-phenylethylamine producer
Enterococcus faecalis grown in absence (A) or presence (B) of tyrosine.
The circle indicated the enzyme TDC (tyrosine/phenylalanine
decarboxylase).
and ADI are both regarded as problematic since they can give
rise to ammonia and undesired bio-active amines such as his-
tamine, that is an allergy mediator, or tyramine which is involved
in hypertension and more severe syndromes such as cerebral
hemorrhage (Millichap and Yee, 2003). Conversely GABA and
beta-phenylethylamine, are appreciated molecules since they can
control appetite, mood, and smooth muscle activity, as it will be
better elucidated in the next paragraphs (Inoue et al., 2003).
LAB proteolytic system
The choice to use amino acids not only as a nitrogen source but
also for energy metabolism, requires high amino acid availability,
and, for this reason, LAB have evolved complex proteolytic and
peptidolytic systems. These include three components: (1) extra-
cellular or membrane bound proteases (mainly PrtP and CEP),
hydrolyzing proteins in oligopeptides; (2) membrane transport
proteins (Opp, Dtp, and Dpp ATP-binding cassette transporters),
catalyzing intracellular uptake of oligopeptides, di/tripeptides,
and dipeptides, respectively; (3) intracellular peptidases, which
cleave peptides into free amino acids (Konings, 2002).
In Lactococci, proteases are prevalently cell-envelope anchored
(CEP proteases), except in Lactococcus lactis subsp. cremoriswhich
is able to secrete proteinases. In Lactobacilli some of them have an
extracellular location (Lb. lactis and Lb. helveticus) while others
are cell-wall associated (Lb. delbruekii ssp bulgaricus). Most LAB
proteolytic enzymes are synthesized as pre-pro-enzymes, whose
signal peptide is cleaved upon membrane translocation: the
resulting membrane bound pro-proteinase undergoes autocat-
alytic cleavage to obtain its mature, active, conformation. These
proteases are serine proteinases, with high molecular weight and
5.5–6.5 pH optima, which is compatible with the environment in
which LAB live.
However, other systems could be present to allow free amino
acid availability at the external side of the cytoplasmicmembrane.
Actually, some peptidases have been detected on the inner face
of the cytoplasmic membrane by antibody recognition (PepX in
Lactococci) or have been supposed to be associated to an anionic
specific permease, although they had been cytosolic-predicted on
the basis of genome sequences data. For instance, PepA does not
bear a signal peptide or a true hydrophobic domain that could jus-
tify its membrane location. Nevertheless, its high substrate speci-
ficity in releasing N-terminal acidic residues from peptides could
account for its role in supplying free glutamate, for the glutamate-
GABA pathway antiporter, at membrane level. In E. faecalis a
similar function can be performed by ClpP: this protease is
able to hydrolyze tetra- and tri-peptides containing the recog-
nition sites tyrosine-tryptophan or tyrosine-leucine (Katayama
et al., 1988). This may result in free tyrosine availability for the
tyrosine-tyramine decarboxylation route.
An important role that is performed by both released and
cell-wall associated LAB proteinases in the human gut are the
digestion of not fully hydrolyzed proteins. They may shorten long
and medium-sized peptides into smaller peptides. This role can
also be played by intracellular peptidases that are released by LAB
cell autolysis. Since the LAB proteolytic system has evolved in
the milk ecological niche, is particularly suitable for diary pro-
tein hydrolysis. Apart from their digestive-assimilative function,
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these enzymes have received great attention because they are
able to generate bio-active peptides from both caseins and milk
whey proteins (Law and Haandrikman, 1997). Diary proteins
are digested in the human stomach and tenuous intestine by
endogenous proteolytic enzymes. This digestion is completed by
proteases supplied by the gut microflora. Casein is made up of
four main proteins: alpha s1 casein, alpha s2 casein, beta-casein,
and k-casein, differing in amino acid sequence, phosphorylation,
and glycosylation degree, hydropaticity index. The hydrolysis of
all these components, whose ratio is about 38:11:38:13, can give
rise to bioactive molecules acting at different biological levels.
Similarly, hydrolytic cleavage of milk whey proteins (alpha lacto
albumine, beta lactoglobulin, lactoferrin, and immunoglobulins)
can also generate bioactive peptides. The proteolytic enzymes that
are released by LAB have been analyzed by 2DE-MS and proved
to be very different in the different LAB species and strains, giv-
ing rise to a different pool of bioactive peptides. However, their
activity, although very high at the normal intestinal pH (6.5–7.0),
proved to be different toward alphas1 and beta casein (Hébert
et al., 1999). The produced peptides are generally stable, although
more investigations are needed to assess their real life span in vivo.
The most interesting bioactive peptides resulting by LAB pro-
teolytic activity are involved in immune system, cardiovascular
system and central nervous system regulation, nutritional supple-
mentation (such as metals assumption), and antimicrobial func-
tions (antibiotic-like compounds). Sometimes each single peptide
can accomplish two or more different physiological functions
(Clare and Swaisgood, 2000).
LAB BIOSYNTHETIC CAPABILITIES
In spite of their limited biosynthetic abilities (especially for amino
acid and vitamin synthesis), LAB can produce molecules of
interest among which the most interesting are exopolysaccha-
rides (EPS) and fructooligosaccharides (FOS), short chain fatty
acids (SCFA), conjugated linoleic acids (CLA), and selenoproteins
(Figure 3).
EPS and FOS
Like most bacteria, LAB can synthesize cell-wall structural
polysaccharides (PS) such as peptidoglycan and lipoteichoic acids
and exocellular polymers. The latter include both capsular PS
where the PS is covalently bound to the cell surface and the EPS
which form a loosely bound slime layer that can also be secreted
into the environment.
EPS can be divided in homopolysaccharides (Homo-EPS)
and heteropolysaccharides (Hetero-EPS). Homo-EPS consist of
either D-glucose (glucans) or D-fructose (fructans) residues, with
different types of linkage and branching degree. Hetero-EPS
are constructed from multiple copies of an oligosaccharide and
show little structural similarity to one another: glucose, galac-
tose, xylose, mannose, arabinose, and rhamnose are the most
represented sugars but also amino-sugars and polyols can be
FIGURE 3 | Molecules contributing to the nutraceutical and probiotic potential of Lactic Acid Bacteria.
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occasionally present as well as glucuronic acid. They are often
highly branched with different binding types. From a biochemical
point of view the synthesis of Hetero-EPS is an energy-intensive
process that requires four separate reactions: (1) sugar internal-
ization; (2) synthesis of sugar nucleotide precursors, providing
the energy for the polymerization reaction; (3) assembly of the
monosaccharide repeating unit by the combined action of dif-
ferent types of glycosyltransferases located at the cytoplasmic
membrane level; (4) export of the EPS. Glucose-6-phosphate
is the key metabolite that can be diverted from the glycolytic
catabolic pathway to be addressed to the synthesis of UDP-glucose
and dTDP-glucose, but also the Leloir route, when present, can
be used to convert galactose to UDPGal and UDPGlu. In mes-
ophylic LAB, the enzymes required for sugar uptake and for
the synthesis of sugar nucleotides are chromosomally encoded,
while the genetic determinants for EPS specific enzymes are plas-
mid located (Laws et al., 2001). Conversely, homo-EPS synthesis
requires only one extracellular glycosyltransferase and the sucrose
is used as substrate instead of activated sugars. This enzyme
can thus synthesize alpha-glucans (dextran, reuteran, mutan)
or beta-fructans (levans and inuline). The low-molecular mass
oligosaccharides are known as FOS and glucooligosaccharides
(Figure 4).
Based on the identification of sucrose binding boxes, several
putative encoding genes for both glucansucrases and fructansu-
crases have been identified in the genome sequences of LAB (van
Hijum et al., 2006).
Generally, LAB divert a small percentage of their sugar sub-
strates toward the biosynthesis of EPS, whose physiological role
is probably diverse and complex: due to their high water-binding
properties, EPS constitute a protection factor against dessication
and osmotic stress (Kumar et al., 2007). Their role in protect-
ing the bacterial cell from phage attack has also been suggested
(Moineau et al., 1996), but more recent experiments failed to
reveal a significant phage resistant phenotype in EPS producer
strains (Deveau et al., 2002). The same is true for the firstly
hypothesized role as extracellular energy/carbon reserve, since
most producers species lack the onset of genes necessary for
their own EPS degradation (Badel et al., 2011). Therefore, this
reserve would constitute a benefit only in the case of sintro-
phyc/symbiotic life with other bacteria. Actually EPS are biosyn-
thesized by most LAB species under quorum-sensing control and
they are related with biofilm formation and adhesion to solid
surfaces. In the biofilm EPS also play a crucial role in sequestering
essential cations (Kumar et al., 2007). In this context, EPS role as
carbon reserve makes sense considering the overall population.
However, their main biological function in vivo is to protect bac-
terial cells from toxic compounds (ethanol, sulphur dioxide, and
toxic metal ions), from antibiotics and from host immune system,
especially phagocytosis. A second important role is connected
with adhesion to eukaryotic cells (plants, tooth surface), cellular
recognition, via binding to lectins (Cerning, 1990), and immune
system modulation. Krinos and co-workers (2001) demonstrated
that, like capsular PS, also EPS can affect the surface antigenicity
of the different strains (different EPS giving rise to different com-
binations) ultimately resulting in maintenance or elimination of
specific strains in the gut ecological niche.
In the past decade fructo-oligosaccharides (FOS = inulin and
levans), have found growing interest as prebiotics, i.e., com-
pounds supporting growth of probiotic organisms. Prebiotics are
molecules that are not metabolized by humans but favor both
adhesion and persistence of probiotic bacteria in the gut environ-
ment. Inulin production has been observed in Lactobacillus reuteri
and all inulosucrases share a common C-terminal motif (LPXTG)
for cell-wall anchoring. Surface display of these enzymes results in
enhanced adhesion of bacteria to human tissue cells, contributing
to the maintenance of a healthy urogenital mucosa. Therefore, the
presence of fructansucrase enzymes in commensal LAB can solve
two distinct problems: from one side helping tissue colonization
and persistence and from the other side supply with “self made”
prebiotics (e.g., fructans) the commensal flora.
SCFA
Although SCFA are not produced by anabolic reaction but rather
as the final catabolites of the energy metabolism, their impor-
tance in host-bacteria interactions is of such growing interest
that will be treated in this paragraph. The most studied SCFA
are butyrate, propionate, and acetate. Lactobacilli can produce
SCFA by the fermentation of pyruvate, which is generated dur-
ing the glycolytic pathway, but also by the phosphoketolase route
in heterofermenting conditions. Acetate can contribute to ennvi-
ronment acidification and this is an appreciated feature since
LAB can compete with other less acidophylic organisms (most
pathogenic bacterial species) present in the same ecosystem.
In vivo acetate enters the peripheral circulation to be metab-
olized by muscles and other tissues, while propionate is taken
up by the liver. Both molecules can modulate sugar metabolism
after a standard meal, by lowering glycaemia and improving
FIGURE 4 | Homopolysaccharides biosynthesized by Lactic Acid Bacteria.
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insulin sensitivity. Butyrate has been claimed to have detrimen-
tal effects on body weight and obesity, since it represents an
additional, easy available, energy source which is not directly
introduced with the diet, but present as the result of commen-
sal bacteria metabolism (non-digestible PS fermentation in the
colon) (Turnbaugh et al., 2006). Once this SCFA is absorbed
in the large intestine, it is not only converted to fat within the
liver but it also positively regulates host genes promoting lipo-
genesis and fat storage into adipocytes (DiBaise et al., 2008).
However, butyrate is readily absorbed by colonocytes where it
exerts a control over uncontrolled proliferation and also stimu-
lates differentiation, thus promoting the switch from neoplastic
to normal phenotypes. It is known that butyrate differently affects
normal colonocytes and tumor colon cells. On the former it
exerts a trophic action inducing growth and proliferation, on
the latter it rather induces cell-cycle arrest, differentiation, and
apoptosis (Iacomino et al., 2001). Butyrate selectivity on the two
different cell populations is considered a good weapon to treat
cancer. The reason of the different effects of butyrate is prob-
ably linked to its different concentrations within the two type
of cells: normal colonocytes rapidly utilize (through mitochon-
drial beta-oxidation) butyrate as the major carbon/energy source
thus supporting ATP synthesis and proliferation. The remaining
low levels cannot suppress cell cycle progression or induce apop-
tosis (Boosalis et al., 2001). On the contrary, colorectal tumor
cells, due to the switch toward anaerobic metabolism, display an
impaired capability to oxidatively catabolize butyrate. Therefore,
in this type of neoplastic cells, its intracellular concentration
is higher. This high level of butyrate may constitute a critical
threshold responsible for the activation of signals that induce cell
cycle arrest, differentiation, and apoptosis (Lupton, 2004). The
effect on cell cycle arrest is partly due to inhibition on specific
histone deacetylase (Davie, 2003), and this action can also be
obtained by the use of propionate, but not acetate. Some authors
also hypothesized that butyrate and propionate act in a synergis-
tic way (Minucci and Pelicci, 2006). Furthermore, comparative
transcriptomic and proteomic studies on butyrate-treated and
control colonocytes, underlined a butyrate effect on extracellular
matrix components which are important in cell–cell interac-
tions, and on the angiogenetic process controlling the expression
level of VEGF (vascular endothelial growth factor) and HIF-
1 (hypoxia-inducible-factor-1) (Pellizzaro et al., 2002). Finally,
butyrate can control oxidative and metabolic stress at molecular
level, by enhancing repair responses (Sauer et al., 2007) and it can
inhibit the synthesis of pro-inflammatory (IL12, TNF, gamma IF)
cytokines, also contributing to tumor development control (Inan
et al., 2000).
It is reasonable to conclude that butyrate can contribute to the
host health when a neoplastic risk is present, while it is a prob-
lematic metabolite in case of obesity and metabolic disorders.
CLA
LAB can also biosynthesize CLA that are positional and geometric
isomers of the cis9, cis12 octa-deca-dienoic acid (linoleic acid). So
far, the best producing strains belong to the genera Lactobacillus
and Streptococcus. The most frequently found isomers of linoleic
acid have the unsaturation site at positions 9, 11 or 10, 12, namely,
trans 9, cis11 octa decadienoic acid, and, in lower amounts,
cis10, trans 12 linoleic acid.
CLA can have positive effects on inflammation, cancer (apop-
tosis induction), metabolic disorders (insulin resistance, body
weight control), and cardio-vascular diseases. Nevertheless, some
detrimental influences onmammalian health have been observed,
like a tumor-stimulating action or deleterious effects on glucose
metabolism and lipid profiles. There is some evidence suggesting
that different CLA isomers can exert differential effects, the more
dangerous being the trans 10, cis 12 isomer. Also CLA concentra-
tions play a role in the balance toward beneficial or detrimental
effects (Rose, 1997): anti-carcinogenic effects are observable at
CLA dosages of 0.5–1% (w:w) of the total diet and studies showed
that humans generally excrete 20mg of linoleic acid per day. This
substrate can then be available for CLA producing bacteria in the
intestine. Higher dietary intake of linoleic acid may imply risks
(Ewaschuk et al., 2006). All these considerations suggest that fur-
ther studies are needed to better characterize CLA producing LAB
and their metabolic products.
LAB selenoproteins biosynthesis
The capability to produce metal-fixing enzymes is a further
appreciated feature in LAB, that render them interesting com-
mensal organisms. Actually, several Lactobacillus species are able
to intracellularly fix sodium selenite (Figure 5) into selenocys-
teins and selenomethionines, thus providing a more bio-available
form of this metal, which is generally poorly adsorbed by human
cells in its inorganic form (Calomme et al., 1995).
The selenocysteine is defined as the 21st amino acid, is encoded
by the UGA codon, and possess its own tRNA, which uses serine
as an intermediate (SerSec t-RNA). Selenomethionine is non-
specifically incorporated into proteins at the place of methionine
and it is also important for trans-selenation reactions. Several
bacterial enzymes have been demonstrated to contain selenocys-
teines in their active site and all belong to the oxidoreductase
class: among these glutathione peroxidase, an enzyme of cru-
cial importance to control oxidative stress and all related dis-
eases in both bacteria and eukaryotic cells. Lactobacillus reuteri,
for instance, express a selenocysteine-lyase (Lamberti et al.,
2011a,b), a PLP-dependent enzyme having a key role for new
FIGURE 5 | Inorganic selenium granules displayed by TEM on the
surface of a selenium-fixing Lactobacillus reuteri strain.
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seleno-proteins biosynthesis, supplying the optimal substrate
(H2Se) to selenophosphate synthetase, which catalyze the pro-
duction of the “activated” selenium form useful to selenocysteine
sinthetase to produce L-selenocysteinil-tRNA (Lacourciere and
Stadtman, 1998). LAB can also function as chelators for other
nutraceutical important metals at the colon level. Investigations
carried out in different prokaryotes leaded to the characterization
of many mechanism for “channeling” zinc (Znll) ions, including
zinc-binding, zinc-importing proteins, and zinc export systems
(Blencowe and Morby, 2003). Zinc-bearing and zinc-extruding
LAB can thus function as immunomodulators useful to control
viral gastroenteritis (Salvatore et al., 2007).
LAB ECOLOGY
The contribution of LAB to the overall intestinal ecosystem has
been only recently elucidated. Traditional culture methods failed
to shed light on the actual microbial populations resident in the
gut of adult humans, but the application of culture-independent
techniques such as PCR combined with DGGE (Denaturing gra-
dient gel electrophoresis) resulted in a more detailed knowledge
of what really happens at gut level. First of all it is impor-
tant to differentiate resident and transient bacteria: Vaughan and
co-workers (2002) reported a list of Lactobacillus species perma-
nently colonizing the intestine: L. acidophilus, L. brevis, L. casei,
L. crispatus, L. delbrueckii, L. fermentum, L. fructivorans, L. gasseri,
L. paracasei, L. plantarum, L. rhamnosus, L. ruminis, L. sakei,
L. salivarius, L. vaginalis. It is worth mention that LAB repre-
sent the 0.01–1.8% of the total bacterial community living in the
human gut (Louis et al., 2007).
LAB–GUT MICROBIOTA INTERACTIONS AND LAB
ANTIBACTERIAL POTENTIAL
Both antagonism and cooperation contribute to the reciprocal
relationships between LAB and other intestinal microorganisms.
Biofilm formation, phage- and pheromones-mediated genetic
exchange and synthrophies are well established strategies for
cooperating with other gut microorganisms. Nonetheless, the
antagonistic behavior is prevalent.
Nutritional, enzymatic, and metabolic competition
Cell wall targeted enzymes such as N-acetylmuramidase and
N-acetylmuramoyl-L-alanine amidase are proteins involved in
peptidoglycan renewal, acting as general cell-wall lysis factors
(Salazar and Asenjo, 2007). They are often produced to control
bacterial populations sharing the same ecological niche. Similarly,
chitinase, a protein hydrolyzing the prominent component of
yeast and fungi cell walls, i.e., chitin, has been found in the
exoproteome of LAB (Genovese, unpublished results).
However, nutrient competition is the best known aspecific
interference, common to all microbial populations, set up by LAB.
Since LAB are predominantly saccharolytic, but also amino acid
utilizers, they can subtract nutrients to both saccharolytic and
proteolytic species living in the gut environment. Furthermore,
their peculiar fermentative metabolism, generating acids, con-
stitutes a specific metabolic competition for coping with other
endogenous or exogenous microbial species together with car-
bon dioxide, ethanol, hydrogen peroxide (produced and fastly
eliminated by the NADH oxidase activity). The direct antimicro-
bial effects of organic acids (lactic, acetic, and propionic acid)
is due to their interference with bacterial cytoplasm membrane
potential and inhibition of active transport, while carbon diox-
ide (formed during LAB heterolactic fermentation) and hydrogen
peroxide prevent the growth of some bacteria by creating an
unfavorable environment.
It is worth noting that the mentioned LAB protelytic activity
toward caseins can also give rise to antimicrobial peptides such as
k-casecidin, a pentapeptide (Phe-Phe-Ser-Asp-Lys) derived by k-
casein hydrolysis, and isracidin, an oligo peptide originated from
alpha s1 casein. Both molecules proved to be very active against
Staphylococus aureus, and the latter also stimulates phagocyto-
sis. Artificial removal of the Lys C-terminal and Phe N-terminal
from k-casecidin strongly reduces the original activity of the
natural pentapeptide (Matin and Otani, 2002). L.acidophylus,
L.plantarum, L.helveticus, L.rhamnosus, and Lactococcus lactis pro-
duce other alpha s1 casein-derived peptides also, which have a
completely different amino acid sequence. The latter proved to
be active against Enterobacter sakazakii, a gram negative species
causing infections in newborns (Hayes et al., 2006).
Bacteriocin production
A promising feature of LAB is the production of interfer-
ence molecules, the bacteriocins (Montalbán-López et al., 2011).
Bacteriocins are proteinaceous molecules that are synthesized at
ribosomal level (and not as secondary metabolites) which can
interfere with the growth of most bacteria. They have bacteri-
cidal action and are selective for prokaryotes. Bacteriocins are
produced at the end of the exponential growth-phase and their
spectrum of action can vary, depending on the producing species.
Producer strains are immune to their own bacteriocins because
they possess genes that encode immunity mechanisms, which
enable a distinction between “self” and “non-self.” Protection can
be provided by a dedicated immunity protein and/or by a special-
ized ABC-transporter system that pumps the bacteriocin outside
the producer membrane (Draper et al., 2009).
LAB are particularly prolific in bacteriocins production and
can biosynthesize different types of antagonistic molecules. The
lantibiotics, so named because they contain post-translationally
modified aminoacids such as lanthionine (two alanines linked
by a sulphur), β-metyl-lanthionine, dehydroalanine, and dehy-
drobutyrine, are small peptides (19–38 amino acids in length)
mainly active against Gram positive bacteria (Figure 6).
They can be divided into two subclasses on the basis of their
structure and mode of action: the elongated amphiphilic cationic
lantibiotics (Nisin, Lactococcin, and Pediocin) are active through
the formation of pores, leading to the dissipation of membrane
potential and the efflux of small metabolites from target cells.
By contrast, the globular lantibiotics (for example, Mersadicin)
act through enzyme inhibition, interfering with cell-wall biosyn-
thesis. The class II bacteriocins are small (<10 kDa) heat-stable
peptides, not undergoing extensive post-translational modifica-
tions, although they may contain D-amino acids. The best known
class II bacteriocin, the so-called pediocin-like, has a narrow but
very specific activity against the food pathogen Listeria mono-
cytogenes (Kazazic et al., 2002). Finally, bacteriolysins are large,
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FIGURE 6 | General structure of a lantibiotic: covalently bound alanines and post-translationally modified amino acids are peculiar features of these
anti-microbial peptides.
heat-labile antimicrobial proteins causing the lysis of sensitive
cells by catalyzing cell-wall hydrolysis. Their structure contains a
catalytic N-terminal domain that shows homologies to endopep-
tidases, and a C-terminus that represents the target recognition
site (Lai et al., 2002).
All these natural antimicrobial compounds are the most inter-
esting antagonist metabolic end-products synthesized by LAB.
Last years’ research has been focused on the study of their iso-
lation, structure, and mechanism of action (Millette et al., 2007).
LAB-HUMAN HOST INTERACTIONS
LAB colonization and diet
LAB, especially Lactobacilli, colonize the new-born as soon as the
infant is breast-fed. On the contrary, artificially-fed new-borns
generally host different bacterial species such as Clostridia and
Bacteroides. The presence of LAB, that are prevalently saccha-
rolytic, acidogenic and bacteriocin producers, acts as a selective
agent, protecting the gut environment from putrefactive and
sulphate-reducing bacteria known to be involved in the pro-
duction of gas, thiols, phenols, indole, histolesive proteases, and
carcinogens (Holzapfel et al., 1998). While sugar fermentations
chiefly occur in the proximal colon (pH 5–6), proteins and pep-
tides putrefaction is typical of the distal colon (pH 7). LAB
presence is maximal in the tenue and proves to be absolutely ben-
eficial for the health and the well being of the host, but, to be
maintained is necessary a specific diet.
Actually, it is well established that diet plays a crucial role
in selecting microbial populations in the complex and dynamic
ecosystem of human gut bacteria. Food containing LAB, such
as yogurt and cheese, can enrich gut LAB populations since
these bacteria can easily survive to the gastric transit. Actually,
LAB are naturally acidophilic organisms (growth pH optimum
3.5–6.5) and they can further improve their acidic pH resis-
tance by setting up strategies that produce alkaline metabolites
(the referred ADI pathway and amino acid decarboxylations
routes). Furthermore, as human or artificial milk can select LAB
or Clostridia in the new-born, similarly, a “meat-fat” rich diet
contributes to select and expand Clostridia in the adult while
a non-metabolizable sugar diet (especially fructose-, inuline-,
and cellulose-rich nutrients that escape regular digestion in the
human body) favors LAB. The epidemiological link between the
“meat-fat” rich diet and colon cancer (Hill, 1975) can partly be
explained by the capability of Clostridia to metabolize bile acids
to carcinogenic molecules responsible for neoplastic transforma-
tion of the gut mucosa (Murray et al., 1980). Thus, the role of LAB
is not only confined to preventing colonization by exogenous bac-
teria but also to cope against toxins and mutagenic molecules of
endogenous origin.
LAB host cross-talk and stress chaperones
It has recently been established that “symbiosis” can trigger adap-
tive responses in both bacteria and host, which are detectable
by transcriptomic and proteomic studies (host-microbiota inter-
actomics), and concern specific metabolic pathways activation,
immune system stimulation/depression, and stress responses.
From the host side, activation of important genes involved
in cell signaling pathways and immunomodulation has been
observed in an in vitro experiment using CaCo-2 epithelial cells
exposed to Lactobacillus acidophilus, a natural inhabitant of the
human small intestine. The use of other food-derived LAB can-
not trigger the same biological response, thus demonstrating that
the long symbiosis has selected peculiar genetic characters for
host-microbe interaction (O’Flaherty and Klaenhammer, 2011).
Furthermore, the importance of LAB cell wall glycome in cytokine
induction in intestinal epithelial cells has been proved with the
use of mutants knock-out for protein glycosylation ability. These
mutants not only failed to stimulate cytokines, but they were
also unable to adhere to CaCo2 cells and showed a significant
impaired persistence in the mice gut environment (Tytgat et al.,
2011).
From the bacterial side, adaptation responses, promoting per-
sistence in the host have been described. In LAB, genetic loci
specifically induced by gut transit are those involved in nutritional
adaptation (hydrolases, ABC transporters, and PTS systems) but
also in anti-stress mechanisms such as membrane modification,
surface glycosylation and anti-oxidative defences (Lebeer et al.,
2011). Bacterial stress protein production (enhanced synthesis of
chaperones GroEL, GroES, DnaK, Hrc, Clp, Cts) in response to
host factors has also been established (Henderson et al., 2006).
It is now well demonstrated that, besides helping correct protein
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folding, chaperones can perform multiple functions such as pre-
venting denaturation, rearranging proteins after oxidative and
pH stress and performing targeted proteolysis on the irreversible
denaturated proteins. Among these functions is the adhesion to
extracellular matrix proteins of the host tissues, and the stim-
ulation of the host immune system. To perform these addi-
tional functions chaperones should be surface or extracellularly
located.
This phenomenon is known as moonlighting and several
moonlighting proteins have been described so far, both in eukarya
and in bacteria, including LAB. They include not only stress
chaperones (GroEL, DNAk) but also glycolytic and TCA cycle
enzymes. Moonlighting proteins are extracellularly transferred
without any export signal and without specific cell-wall or mem-
brane anchoring motif: thus the surface or extracellular local-
ization can be related to the environmental pH. Antikainen and
co-workers (Antikainen et al., 2007a) demonstrated that higher
extracellular pH can cause release of the weakly linked proteins
in Lactobacillus crispatus but cell-wall renewal, that is frequent
during the exponential growth phase, can also be involved in
the detachment of such proteins (Sánchez et al., 2008). Generally
surface-exposed and released moonlighting proteins exert differ-
ent biological functions, namely adhesion (cell-wall bound) and
immune system modulation (extracellular chaperones).
LAB adhesion to host tissues and immunomodulation
Adhesion. The bacteria-human mucosa interaction is a dynamic
equilibrium and several factors can alterate this balance. Intestinal
movements and bacterial chemotaxis cause a weak association
between bacteria and the surface of the gut epithelium where
electrostatic and hydrophobic bonds are prevalent. In a following
step, a more specific interaction between molecular determinants
on bacterial surface and specific gut mucosa receptors occurs.
Specific targets on human tissues are collagen type I and IV,
fibronectin, and laminin. In LAB, good binding-effectors are PS,
lipoteichoic acids as well as proteins such as lectins and adhesines.
The adhesion potential of a certain LAB strain is therefore crucial
for survival and persistence in the gut environment.
Several surface located moonlighting proteins can act as
adhesines. Both the chaperone GroEL and an elongation fac-
tor, EF-Tu, display adhesive capabilities, toward human tissues in
Lactobacillus johnsonii. EF-Tu is a guanosine nucleotide binding
protein playing a central role in protein synthesis (when expressed
inside the cell) but able to bind fibronectin or mucine and
epithelial cells when exposed on the cell surface (Granato et al.,
2004). Trigger factor is also connected with adhesion: it has been
described to be exposed on the surface of Lactobacillus plantarum
and, in L. reuteri NCIB11951, a collagen I binding protein, shares
high sequence homology with E. coli trigger factor (Aleljung et al.,
1994). Apart from these proteins, also glycolytic enzymes can have
adhesive properties: GAPDH is able to bind fibronectin, plasmin,
and mucine in several bacterial species (Alvarez et al., 2003) and a
similar role may be performed by PGK (phosphoglycerate kinase)
that is referred to be extracellularly located in Lactobacillus rham-
nosus GG (Sánchez et al., 2008). Some of these proteins will be
treated in a separated chapter for their peculiar attitude to behave
also as plasminogen receptors.
Immune systemmodulation. About 70% of the immune system
is localized in the gastro-intestinal tract as GALT (gut-associated
lymphoid tissue). A reciprocal relationship exists between LAB
and immune system. From one side the immune system selects
the LAB species to be accepted from the other side LAB can mod-
ulate immunological functions. The most evident LAB’s effects
concern the enhancement of the ratio between anti-inflammatory
(IL-10, β-TGF) and pro- inflammatory (IL-1 beta, IL-3, IL-4)
cytokines (Pessi et al., 2000) and the selection of T-lymphocyte
populations (Karimi et al., 2009). Different LAB components,
such as teichoic and lipoteichoich acids, lipoproteins, and EPS
may be the inducers of the immune response (Weidenmaier
and Peschel, 2008). Some of the referred adhesive proteins also
exhibit immunomodulatory properties when they are secreted.
This is particularly true for the chaperone GroEL which has
been demonstrated to interact with macrophages and stimu-
late cytokines secretion. In L. johnsonii GroEL also induces a
strong aggregation of the pathogen Helicobacter pylori, contribut-
ing to decrease of the bacterial load and thus facilitating clear-
ance of the aggregated pathogens by the mucus (Granato et al.,
2004). In L. reuteri a strict link between adhesion and regula-
tory T-cell induction has been demonstrated as well (Smits et al.,
2005). Last but not least, an indirect immune stimulating activ-
ity can be triggered by proteolytic intestinal LAB species through
the production of immunomodulating peptides from casein.
These molecules primarly enhance lymphocyte proliferation and
macrophage phagocytosis but they are probably important in reg-
ulating the development of the immune system in new borns
and might contribute to attenuate allergic reaction and tumor
development as well (Korhonen and Pihlanto, 2006).
LAB interactionwith the plasminogen-plasmin system
Lactobacillus crispatus, Lactobacillus acidophilus, L. amylovorus,
L. gallinarum, L. gasseri, and Lactobacillus johnsonii display the
ability to bind plasminogen on their cell wall (Hurmalainen
et al., 2007). Several adhesion-involved glycolytic enzymes (eno-
lase, GAPDH, phosphoglycerate kinase, and phosphoglycerate
mutase), bile salts hydrolase and the stress protein DnaK, have
been demonstrated to behave as plasminogen (Pg) receptors.
They all share a common feature, a C-terminus lysine. Some
reports suggest that plasminogen binding capability in LAB can
constitute a risk because plasminogen can be activated to plas-
min thus triggering further proteolytic cascades, resulting in
the degradation of the gut extracellular matrix. Nevertheless,
LAB lack the intrinsic potential for plasminogen activation typ-
ical of pathogenic species. Actually, pathogenic bacteria like
Staphylococcus aureus and Streptococcus pneumoniae can convert
plasminogen into plasmin by specific virulence factors (staphy-
lokinases and streptokinases, respectively) (Bergmann et al.,
2003) that, so far, were never found in the genome of LAB.
According to some authors (Antikainen et al., 2007b) LAB can
exploit the endogenous system of the host (urokinase and tissue
plasminogen activators) to trigger proteolysis, according to others
(Sánchez et al., 2008). LAB can quench plasminogen, subtracting
it from pathogenic bacteria. At present, this is still a controversial
question concerning LAB and more research is needed to fully
shed light on this bacteria-host interaction aspect.
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LAB PROVED BENEFICIAL ACTIONS ON HUMAN HEALTH
The most important beneficial interactions between gut LAB and
humans include metabolism regulation, infection control, and
inflammation/allergy modulation. The last three effects are in




LAB can enhance energy recovery from nutrients by degrading
non-metabolizable sugars and supply the host with their own
β-galactosidase thus by-passing enzymatic lactose intolerance.
Some casein phosphopeptides (CPP) show the capacity of main-
taining in solution calcium ions, even in alkaline pH. This results
in increased absorption of calcium useful in osteoporosis, but
also in enhanced absorption of iron, zinc, and manganese, useful
as enzyme co-factors or prostetic groups. To perform this func-
tion is necessary that LAB digest casein, especially alpha s1 and
alpha s2 caseins, releasing CPP phosphorylated on Ser and Thr
residues. Since beta and k-caseins are poor in hydroxylated amino
acids, they are less suitable for phosporylation, and the pep-
tides derived from them are less active in metal binding (Meisel,
1998).
Cholesterol-lowering
When released in the gut by LAB, SCFA can cause a decrease in
the hepatic cholesterol synthesis and a redistribution of choles-
terol from blood to the liver (Pereira and Gibson, 2002). Also
deconjugation of bile acids by LAB can play a similar role in
plasma cholesterol-lowering. Deconjugated bile acids are not
well absorbed by the gut mucosa and therefore excreted. As a
consequence, new cholesterol is driven from blood to liver, for
de novo bile acid synthesis (St-Onge et al., 2000). In Lactobacillus
reuteri a specific choloylglycine hydrolase, catalyzing the initial
gateway reaction for bile acids deconjugation, is biosynthesized
(Martoni et al., 2008). Cholesterol-lowering capability has also
been demonstrated by LAB-produced EPS (Pigeon et al., 2002).
Benefits on cardiovascular pathologies and hearth disease are thus
expected.
INFECTION AND IMMUNOMODULATION
LAB have longly been known as being able to control infec-
tions because of their direct antibacterial action (mediated by
bacteriocins and acid production) and to their indirect (immuno-
logically mediated) action against viruses. The role of Lactobacilli
in preventing traveller’s diarrhea, growth of Helicobacter pylori
and toxin producing E. coli has been demonstrated in both
in vitro and in vivo studies. Lactobacillus rhamnosus GG has also
been successfully employed for preventing C. difficile colitis, as
well as to treat atopic eczema by means of modulation over
Interleukin-10 (Pessi et al., 2000), while Lactobacillus reuteri can
control IgE-mediated allergies by acting at regulatory T cells level
(Karimi et al., 2009). Antiinflammatory (Kitazawa et al., 1998)
and antitumoral activities have also been reported to be due to
LAB-produced EPS. Rhamnose Hetero-EPS proved to be effec-
tive against gastric ulcer (Badel et al., 2011) and a stimulation of
TNF has been demonstated (DeVuyst et al., 2007). Experiments
using cocktails of Lactobacillus and Bifidobacterium also revealed
the ability to cause apoptosis of colon carcinomas.
INFORMATIONAL MOLECULES AND OXIDATIVE STRESS
A very cutting-edge evidence is the possibility that LAB can con-
trol both the human antioxidant defences and the production
of informational molecules acting on mood, blood pressure, and
more generally on the gut-brain axis.
Lactobacillus helveticus, Lactobacillus delbrueckii subsp. bul-
garicus SS1, and Lactococcus lactis subsp. cremoris FT4 can all
modulate blood pressure by producing angiotensin 1-converting
enzyme inhibitory peptides (ACE inhibitors) from milk pro-
teins. The most active molecules are tripeptides made up of
Val-Pro-Pro and Ile-Pro-Pro, but other, casein-derived, antihy-
perthensive peptides like alpha s1 casokinin-5 (Phe-Phe-Val-Ala-
Pro), alpha s1 casokinin-6 (Thre-Thre-Met-Pro-Leu-Trp), beta-
casokinin (Lys-Val-Leu-Pro-Val), and a dipeptide Tyr-Pro, proved
to be effective in blood pressure control as well (Yamamoto et al.,
1999). Since their production is the result of the proteolytic activ-
ity of some LAB strains over casein, it is dependent upon casein
availability in the intestine and from the proteolytic potential
of each single strain. Generally LAB peptidases, by shortening
the poly/oligopeptide chain, contribute to enhance the anti ACE
potential. Interestingly, the final active short peptides are resistant
to both pH variations and human digestive enzymes (Sipola et al.,
2002; Gobbetti et al., 2004). Antithrombotic peptides derived
from human and bovine k-caseinglycopeptides have also been
found in five-days-old newborns after breast and formula feed-
ing, respectively (Chabance et al., 1995). Even if these molecules
can be produced as the result of human proteolysis on food,
LAB proteolytic activity on casein can for sure contribute to
their release in vivo. These molecules, named casoplatelin and
thrombin inhibitory peptide, are 6–11 amino acids long oligopep-
tides, preventing the aggregation of ADP-activated platelets and
the binding of human fibrinogen (lambda chain) on the platelet
surface receptor. A shorter molecule, casopiastrin, also displayed
fibrinogen binding inhibiting activity (Jollès et al., 1986).
The most interesting molecules produced with the contribu-
tion of LAB protease system on dairy food are the opioid peptides
(exorphins) and opioid antagonist peptides (casoxins). In mam-
mals’ central and peripheral nervous system there are receptors
(K, delta, and mu) for endogenously produced opioid peptides
(endorphins) which have inhibitory activity on adenylate cyclase
enzyme. Protein fragments with opioid-like activity have been
found as the result of both human digestive pH/proteases and
microbial proteases over casein molecules. These peptides are
made-up of 4–10 aminoacids and can trigger a myorelaxant effect
by acting on the mu receptors (beta-casomorphins) or on the
delta receptor (alpha s1 casein-derived peptide). The N-terminal
residue, which is crucial for triggering biological activity, is Tyr
in beta-casomorphins and Arg in alpha s1 casein-derived peptide
(Loukas et al., 1983). Nevertheless, the two molecules display dif-
ferent half-life due to their different structure and the presence
of several proline residues (six) in beta-casomorphins seem to be
the factor enhancing peptide resistance to enzymatic digestion in
human digestive tract. Here they can affect intestinal transit time,
water balance, and aminoacid uptake. Once absorbed into blood,
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they reach the brain and peripheral receptors where they exert
their relaxing action inducing sleeping and calmness (Chabance
et al., 1998). Opposite to this action is the anti-oppioid activ-
ity displayed by peptides derived from k-casein hydrolysis. These
molecules called casoxins function as oppioid-antagonists over
both the mu and k-type receptors. Their possible physiological
action on human is counteracting the life-threatening depres-
sion of the CNS and respiratory system (Chiba and Yoshikawa,
1986). Finally, some peptides derived from casein by LAB pro-
teolys can exert mixed functions such as morphine-like and
immunostimulating (Kayser and Meisel, 1996).
Some Lactobacillus (Cho et al., 2007) and Lactococcus species
(Mazzoli et al., 2010) are also able to produce, by glutamate decar-
boxylation (see paragraph on energy metabolism), GABA, the
most widely distributed neurotransmitter in the vertebrate cen-
tral nervous system, that also acts as modulatory effector at the
gut level. Although GABA cannot by-pass the blood-brain bar-
rier, it can act as a relaxing molecule over the gut smooth muscles,
can lower the blood pressure in mild hypertensive patients (Inoue
et al., 2003) and also plays regulatory and trophic roles on pan-
creas (Erlander et al., 1991). Even if not all the cited LAB are stable
inhabitants of human gut, they can be acquired by food and can
persist in suitable conditions.
For what concerns the antioxidant potential, as referred in a
previous paragraph, some LAB strains are able to fix inorganic
selenite into seleno amino acids thus opening the possibility to
biosynthesize in vivo selenoproteins, essential factors for oxidative
stress control. Selenium has been demonstrated to be a nutri-
tionally essential trace element since 1957 (Schwarz and Foltz,
1957). However, dietary selenium intake vary widely among dif-
ferent countries, from 7mcg per day in China up to 100–200mcg
of Canada, USA, and Venezuela (Rayman, 2008). The reason of
such differences lies in the different soils in which vegetables are
grown and animal are raised. It is now evident that the sele-
nium content of food is strictly linked to soil selenium availability
and where this availability is scarse severe endemic selenium defi-
ciencies occur (Zhao et al., 2007). Furthermore, serum selenium
concentrations reflect food selenium content, thus demonstrating
that no alternative endogenous way to get this metal is possible
(Combs, 2001).
Even if it is widely accepted that selenium deficiency (exception
made for very specific and rare syndroms) does not cause ill-
ness by itself, nevertheless, this metal appears to be a key nutrient
for countracting bacterial and viral infections (Beck et al., 2003),
for thyroid hormone balance (Tinggi, 2008), for limiting oxi-
dized LDL associated atherogenesis and consequent heart disease
(Furman et al., 2004), and for controlling age-related disorders
such as oxidative status, immunodeficiency, general inflamma-
tion (Méplan, 2011), and prostate cancer (Klein et al., 2003).
Many evidences suggest a cancer-protective effect of selenium
supplementation since this metal proves to be an effective tool for
controlling DNA damage risk associated with neoplastic degener-
ation. An inverse correlation between selenium blood levels and
cancer mortality has also been observed.
The recommended dietary intake of selenium for humans is
55mcg per day (Alzate et al., 2008). The Lactobacillus biosynthe-
sized selenium proteins not only represent a more bioavailable
dietary source but there is also a correlation between this organic
form and the concentration of this metal in the external environ-
ment, opening interesting perspectives on metal release in the gut
environment by LAB, with consequent oxidative stress control.
LAB LIGHTS AND SHADOWS
LAB, like every organism on this earth, are not perfect. The
described metabolic and biochemical features underline the risk
that they can produce toxic metabolites suh as ammonia and
bio-active undesired amines like histamine and tyramine. Their
ability to produce butyrate can be severely evaluated when a
metabolic syndrome is present since this metabolite, although
having a protective effect against neoplastic degeneration, can
increase the human calories gain and also inhibit lypolytic pro-
cesses. Similarly, some CLA isomers produced by LAB could be
deleterious, so a careful typing of gut LAB single strains and
their metabolites can help to avoid undesiderd effects. For what
concerns the ability to activate plasmin-mediated proteolytic
cascades, by using endogenous factors, this risk is counterbal-
anced by the possible quenching effect of released palsminogen
receptors on the plasminogen itself.
A separate comment is needed for the Genus Enterococcus.
While some species like E. faecium are currently considered safe
and even employed as starters in the food industry and as probi-
otics in both food and pharmaceutical preparations, other species
like E. faecalis can cause problems due to different reasons. It
should be remembered that enterococci are more tolerant to salt,
less acidophilic, and less acydogenic than other LAB, thus con-
stituting a group per se. First of all they are naturally resistant
to many antimicrobial agents, and also bear transmissible antibi-
otic resistance factors. Furthermore, their pheromone production
is very high thus enhancing the frequency of recombination. A
second risk is linked to the fact that most pathogenicity char-
acters expressed by enterococci are not species but rather strain
related. Among these are worth mentioning gelatinase, serine
proteases, endocarditis antigen, and the aggregation factor. A fur-
ther problem is connected with the oxidative catabolism of steroid
molecules. During their enterohepatic circulation, bile acids are
bio-transformed by the intestinal microbiota into a variety of
metabolites some of which are carcinogenics, especially the C7
dehydroxy- and the C7 keto-derivatives (Murray et al., 1980).
Although dehydrogenation, epimerization, and dehydroxylation
are mainly peformed by Clostridia, also some Enterococcus faecalis
strains have been reported to have C7 dehydroxylating activity.
These reactions are directed not only toward bile acids or choles-
terol but also to different steroid molecules present in the gut
(Groh et al., 1993).
It is always difficult to establish once and for all when the
benefits are higher than the risks, especially when dealing with
bacteria, whose frequency of mutation, genetic recombination,
and evolution can change the scenario in few years. Only some
decades ago E. coli was considered safe and Clostridia highly
pathogenic. Nowadays, some E. coli strains have been proved
to cause death and Clostridia have even been proposed as pro-
biotics (Cartman, 2011). For sure the “omics” approach can
help us, now and in the near future, to shed light on some
controversial aspects still concerning LAB biology, and on how
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environmental condition can affect their biology. Nevertheless,
considering the absence of the main bacterial pathogenicity char-
acters (toxins, invasion potential) and all the beneficial traits
supplied by LAB in the context of the gut ecosystem (acidifi-
cation, prebiotic FOS biosynthesis, lactose recovery, bacteriocins
release, positive bio-active molecules production acting on mood
and appetite, immune system modulation, and selenium organ-
ication) we can conclude that this group of bacteria, is not only
well adapted to live as commensal with humans, but can also help
the human host to maintan his/her healty status and, may be, to
enhance his/her performances and longevity.
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